+67.5%
MET vs BBIO
+154.4%
-87.0%
-22.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.4% | -0.1% | +0.5% | +0.4% |
| 7D | -0.5% | -3.2% | +2.7% | -0.2% |
| 30D | +0.5% | -13.6% | +14.1% | +2.0% |
| 3M | +11.6% | +7.2% | +4.4% | +10.4% |
| 6M | +40.8% | +1.5% | +39.3% | +39.9% |
| YTD | +25.7% | -5.3% | +31.0% | +25.4% |
| 1Y | +24.4% | +37.7% | -13.4% | +18.7% |
| 3Y | +67.5% | +153.9% | -86.4% | +42.1% |
| All | +67.5% | +154.4% | -87.0% | +42.1% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling